Skip to content
Demo
‹ Back to IndustriesHealthcare

How Technology Can Save You from Having a Heart Attack

The pandemic has had a large impact on healthcare, and few people know that better the Dr. Waqaas Al-Siddiq, the founder and CEO of Biotricity. His company’s remote cardiac monitoring technology saves lives by allowing for the kinds of monitoring and data collection necessary to maintain proper heart health. As telemedicine has grown in…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The pandemic has had a large impact on healthcare, and few people know that better the Dr. Waqaas Al-Siddiq, the founder and CEO of Biotricity.

His company’s remote cardiac monitoring technology saves lives by allowing for the kinds of monitoring and data collection necessary to maintain proper heart health. As telemedicine has grown in prominence, so too has the willingness to adopt new technologies to battle these serious and chronic heart issues.

Obstacles remain on the insurance side, however. Dr. Al-Siddiq believes that insurance education is key when interacting with customers.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Book a Demo →Talk to Sales

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

Book a Demo →Try it Free

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Moderna swings to a profit and raises its 2026 revenue outlook as newer vaccines gain traction

Moderna swings to a profit and raises its 2026 revenue outlook as newer vaccines gain traction

Moderna reported third-quarter revenue of $1.31 billion, up 29%, and net income of $162 million, compared with a $200 million loss a year earlier. International COVID vaccine sales under long-term government partnerships and the full-year impact of its next-generation COVID vaccine drove growth, while lower costs helped the profit. The company raised its 2026 revenue growth outlook to 15% to 25% from up to 10%. Its flu shot, mFLUSIVA, was approved in the U.S. and will have a limited U.S. launch in 2026.

  • 01Third-quarter revenue rose 29% to $1.31 billion, with $780 million in the U.S. and $533 million internationally.
  • 02Net income was $162 million, or 38 cents per share, versus a $200 million loss a year earlier.
  • 03Moderna now expects 2026 revenue growth of 15% to 25%, up from up to 10%.

Nov 6, 2026

Why legacy EHR data decides whether healthcare AI pays off

Why legacy EHR data decides whether healthcare AI pays off

MediQuaid director of client services Jason Tennison, a former bedside nurse, discussed EHR replacement data challenges on the Scopewell podcast, where host James Leuthe credited him with an analogy that clean, governed data is the foundation AI needs. Clearsense says a national health system retired more than 800 legacy systems and generated over $100 million in recurring annual operating savings by archiving inactive records, and Harmony Healthcare IT’s 2023 CHIME CIO survey found 94% still operating on legacy applications.

  • 01A national health system retired more than 800 legacy systems and booked over $100 million in recurring annual operating savings by archiving inactive records, Clearsense says.
  • 02Harmony Healthcare IT's 2023 survey of health care CIOs found 94% still run legacy applications, and the average hospital carries 10 EHRs.
  • 03Across industries, 52% of chief data officers rate their generative AI data readiness inadequate, per an AWS and Harvard Business Review survey reported by HealthTech Magazine.

Nov 6, 2026

Censis now reads da Vinci 2D codes to count arm uses

Censis now reads da Vinci 2D codes to count arm uses

Censis Technologies told CtUC 2026 attendees that CensiTrac has read the 2D matrix code on da Vinci arms since April, so robotic arms carry use counts without a second mark. The session built a business case for CensiTrac Advanced around marked assembly, clinic inventory ownership and par levels, with a 2021 BMJ Quality & Safety study putting missing instruments at 17.6% of assembly defects.

  • 01CensiTrac has counted da Vinci arm uses from the code that already comes on each arm since April, with no laser or etch added.
  • 02Hospitals told Censis they want clinic inventory tracking mainly to prove sterile processing did not lose the instruments.
  • 03Missing instruments were 17.6% of assembly tray defects at a 700-bed hospital in a 2021 BMJ Quality & Safety study, a problem the presenter tied to marked assembly.

Nov 5, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For Healthcare teams

See how Healthcare teams use MarketScale →

Executive Thought Leadership

Explore Channels

Industry news, analysis, and expert perspectives

Professional AV›Engineering & Construction›Education Technology›Healthcare›Energy›Software & Technology›Retail›Business Services›Industrial IoT›Sports & Entertainment›Transportation›Sciences›Building Management›Food & Beverage›Architecture & Design›Hospitality›Marketing Tech›
Keep exploring

More from Healthcare

Healthcare hubMore expert Healthcare coverage.Explore →Executive Thought LeadershipPut clinical leaders on the record.Explore →CooperVisionMedical device storytelling.Explore →State of GEO & AI VisibilityHow B2B brands get cited by AI search.Explore →

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512